Quercetin attenuates nuclear factor-κB activation and nitric oxide production in interleukin-1β-activated rat hepatocytes

Journal of Nutrition

Volumn 135, Issue 6, 2005, Pages 1359-1365

  Martínez Flórez, Susana ^a   Gutiérrez Fernández, Belén ^a   Sánchez Campos, Sonia ^a   González Gallego, Javier ^a   Tunon, Maria J ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Interleukin 1 ; Nitric oxide; Nuclear factor B; Quercetin; Rat cultured hepatocytes

Indexed keywords

DICHLORODIHYDROFLUORESCEIN DIACETATE; GLUTATHIONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; INHIBITION KINETICS; LIVER CELL CULTURE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 20444424991     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.6.1359     Document Type: Article

References (55)

1. Dinarello, C. A. (1997) Interleukin-1. Cytokine Growth Factor Rev. 8: 253-265.
2. Dinarello, C. A. (2004) Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr. Opin. Pharmacol. 4: 4378-4385.
3. Hanada, A. & Yoshimura, A. (2002) Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13: 413-421.
4. Andus, T. & Bauer, J. (1991) Effects of cytokines on the liver. Hepatology 13: 364-375.
5. Llorent, L., Richaud-Patin, Y., Alcocer-Castillejos, N., Ruiz-Soto, R., Mercado, M. A., Orozco, H., Gamboa-Domínguez, A. & Alcocer-Varela, J. (1996) Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J. Hepatol. 24: 553-563.
6. Diehl, A. M. (1999) Cytokines and the molecular mechanisms of alcoholic liver disease. Alcohol Clin. Exp. Res. 23: 1419-1424.
7. Geller, D. A., Freeswick, P. D., Nguyen, D., Nussler, A. K., Di Silvio, M., Shapiro, R. A., Wang, S. C., Simmons, R. L. & Billiar, T. R. (1994) Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response. Arch. Surg. 129: 165-171.
8. Kang, Y. H., Berthiaume, F. & Yarmush, M. L. (2002) Long-term stable cultures of rat hepatocytes: an in vitro model to study acute and chronic hepatic inflammation. Tissue Eng. 8: 681-693.
9. Manjeet, R. & Ghosh, K. B. (1999) Quercetin inhibits LPS-induced nitric oxide and tumour necrosis factor-α production in murine macrophages. Int. J. Immunopharmacol. 21: 435-443.
10. Liaudet, L., García-Soriano, F. & Szabo, C. (2000) Biology of nitric oxide signalling. Crit. Care Med. 28: N37-N52.
11. 2 production. Eur. J. Pharmacol. 446: 187-194.
12. Olszanecki, R., Gebska, A., Kozlovski, V. I. & Gryglewski, R. J. (2002) Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol. 53: 571-584.
13. Fujimori, K., Fujitani, Y., Kadoyama, K., Kumanogoh, H., Ishikawa, K. & Urade, Y. (2003) Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin 1-beta via two NF-kappa B elements in rat leptomeningeal cells. J. Biol. Chem. 278: 6018-6026.
14. Jiang, B., Xu, S., Brecher, P. & Cohen, R. A. (2002) Growth factors enhance interleukin 1-beta induced persistent activation of nuclear factor kappa B in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 22: 1811-1816.
15. Baeuerle, P. A. & Henkel, T. (1994) Function and activation of NF-kappaB in the immune system. Annu. Rev. Cell Biol. 12: 141-179.
16. Nunokawa, Y., Oikawa, S. & Tanaka, S. (1996) Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor κB dependent mechanism. Biochem. Biophys. Res. Commun. 223: 347-352.
17. Hertog, M.G.L. & Hollman, P.C.H. (1996) Potential health effects of the dietary fiavonol quercetin. Eur. J. Clin. Nutr. 50: 63-71.
18. Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G. & Goldberg, D. M. (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation in eicosanoid synthesis: implication for protection against coronary heart disease. Clin. Chim. Acta 23: 207-219.
19. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C.W.W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C. & Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Washington, DC) 275: 218-221.
20. Jovanovic, S. V., Steenken, S., Simic, M. G. & Hara, Y. (1998) Antioxidant properties of flavonoids: reduction potentials and electron transfer reactions of flavonoid radicals. In: Flavonoids in Health and Disease (Rice-Evans, C. & Packer, L., eds.), pp. 137-161. Marcel Dekker, New York, NY.
21. Shih, C. M., Lin, H., Liang, Y. C., Lee, W. S., Bi, W. F. & Juan, S. H. (2004) Concentration-dependent differential effects of quercetin on rat aortic smooth muscle cells. Eur. J. Pharmacol. 496: 41-48.
22. Chen, Y. C., Shen, S. C., Lee, W. R., Hou, W. C., Yang, L. L. & Lee, T. J. (2001) Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin, and quercetin pentacetate in RAW 264.7 macrophages. J. Cell Biochem. 82: 537-548.
23. Raso, G. M., Meli, R., Di Carlo, G., Pacilio, M. & Di Carlo, R. (2001) Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A. 1. Life Sci. 68: 921-931.
24. Kawada, N., Skei, S., Inoue, M. & Kuroki, T. (1998) Effect of antioxidants, resveratrol, quercetin and N-acetylcysteine on the function of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27: 1265-1274.
25. Soliman, K.F.A. & Mazzio, E. A. (1998) In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc. Soc. Exp. Biol. Med. 218: 390-397.
26. Sato, M., Miyazaki, T., Kambe, F., Maeda, K. & Seo, H. (1997) Quercetin, a bioflavonoid, inhibits the induction of interleukin-monocyte chemoattractant protein-1 expression by tumour necrosis factor-alpha in cultured human synovial cells. J. Rheumatol. 24: 1680-1684.
27. Rangan, G. K., Wang, Y., Tay, Y. & Harris, D.C.H. (1999) Inhibition of NF-κB activation with antioxidants is correlated with reduced cytokine transcription in PTC. Am. J. Physiol. 46: F779-F789.
28. Wadsworth, T. L. & Koop, D. R. (1999) Effects of the wine polyphenols quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57: 941-949.
29. Green, L. C., Wagner, D. A., Glogowski, P. L., Skipper, J. S., Wishnok, J. S. & Tannenbaum, S. R. (1982) Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126: 131-138.
30. Tuñón, M. J., Sánchez-Campos, S., Gutiérrez, B. & González-Gallego, J. (2003) Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappaB activation in rat hepatocytes. Biochem. Pharmacol. 66: 439-445.
31. Hissin, J. & Hill, R. A. (1976) Fluorimetric method for determination of oxidised and reduced glutathione in tissues. Anal. Biochem. 74: 214-226.
32. Essani, N. A., McGuire, G. M., Manning, A. M. & Jaeschke, H. (1996) Endotoxin-induced activation of the nuclear transcription factor NF-κB in hepatocytes, Kupffer cells and endothelial cells in vivo. J. Immunol. 156: 2956-2963.
33. Hensley, K., Robinson, K. A., Gabbita, S., Salsman, S. & Floyd, R. A. (2000) Reactive oxygen species, cell signalling, and cell injury. Free Radic. Biol. Med. 28: 1456-1462.
34. Cho, S. Y., Park, S. J., Kwon, M. J., Jeong, T. S., Bok, S. H., Chol, W. Y., Jeong, W. I., Ryu, S. Y., Do, S. H., Lee, C. S., Song, J. C. & Jeong, K. S. (2003) Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophages. Mol. Cell. Biol. 243: 153-160.
35. Moreira, J. A., Fraga, C., Alonso, M., Collado, P. S., Zettler, C., Marroni, C., Marroni, N. & González-Gallego, J. (2004) Quercetin prevents oxidative stress and NF-κB activation in gastric mucosa of portal hypertensive rats. Biochem. Pharmacol. 68: 1939-1946.
36. Chan, M.M.Y., Mattiacci, J. A., Hwang, H. S., Shah, A. & Fong, D. (2000) Synergy between ethanol and grape polyphenols, quercetin and resveratrol, in the inhibition of inducible nitric oxide synthase pathway. Biochem. Pharmacol. 60: 1439-1448.
37. Middleton, E., Kandaswami, C. & Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52: 673-751.
38. Robak, J., Shridi, F., Wolbis, M. & Krolikowska, M. (1988) Screening of the influence of flavonoids on lypoxygenase and cyclooxygenase activity, as well as nonenzymic lipid oxidation. Pol. J. Pharmacol. Pharm. 40: 451-458.
39. Jiang, B., Xu, S., Hou, X., Pimentel, D. R., Brecher, P. & Cohen, R. A. (2004) Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1 beta-induced gene expression. J. Biol. Chem. 279: 1323-1329.
40. Orzechowski, A., Grzelkowska, K., Zimowska, W., Skierski, J., Ploszaj, T., Bachanek, K., Motyl, T., Karlik, W. & Filipecki, M. (2000) Induction of apoptosis and NF-kappa B by quercetin in growing murine L1210 lymphocytic leukemic cells potentiated by TNF-alpha. Reprod. Nutr. Dev. 40: 441-465.
41. Rangan, G. K., Wang, Y. & Harris, D. C. (2002) Dietary quercetin augments activator protein-1 and does not reduce nuclear factor-kappa B in the renal cortex of rats with established chronic glomerular disease. Nephron 90: 313-319.
42. Kobuchi, H., Droy-Lefaix, M. T., Christen, Y. & Packer, L. (1997) Gingko biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem. Pharmacol. 53: 897-903.
43. Cho, D. I., Koo, N. Y., Chung, W. J., Kim, T. S., Ryu, S. Y., Im, S. Y. & Kim, K. M. (2002) Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: structural requirements and mechanisms of action. Life Sci. 71: 2071-2082.
44. 2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis 19: 1583-1589.
45. Muraoka, K., Shimizu, K., Sun, X., Tani, T., Izumi, R., Miwa, K. & Yamamoto, K. (2002) Flavonoids exert diverse inhibitory effects in the activation of NF-κB. Transplant. Proc. 34: 1335-1340.
46. Schreck, R., Meier, D. N., Mannel, W., Droge, W. & Bauerle, P. A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cell. J. Exp. Med. 175: 1185-1194.
47. Brigelius-Flohe, R., Banning, A., Kny, M. & Bol, G. F. (2004) Redox events in interleukin-1 signaling. Arch. Biochem. Biophys. 423: 66-73.
48. Choi, C., Cho, H., Park, J., Cho, C. & Song, Y. (2003) Suppressive effects of genistein on oxidative stress and NFkappaB activation in RAW 264.7 macrophages. Biosci. Biotechnol. Biochem. 67: 1916-1922.
49. Vos, T. A., Van Goor, H., Tuyt, L., Jager-Krikken, A., Leuvenink, R., Kuipers, F., Jansen, P. L. & Moshage, H. (1999) Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology 29: 421-426.
50. Myhrstad, M.C.W., Carlsen, H., Nordstrom, O., Blomhoff, R., Moskaug, J. O. (2002) Flavonoids increase the intracellular glutathione level by transactivation of the γ-glutamylcysteine synthetase catalytical subunit promoter. Free Radic. Biol. Med. 32: 386-93.
51. Staal, F.J.T., Roederer, M., Herzenberg, L. A. & Herzeneberg, L. A. (1990) Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 87: 9943-9947.
52. Romics, L., Kodys, K., Dolganiuc, A., Graham, L., Velayudham, A., Mandrekar, P. & Szabo, G. (2004) Diverse regulation of NF-κB and peroxisome proliferators-activated receptors in murine non-alcoholic fatty liver. Hepatology 40: 376-385.
53. Xie, Q. & Nathan, C. (1994) The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 56: 576-682.
54. Peet, G. W. & Li, J. (1999) IKappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporin and quercetin. J. Biol. Chem. 274: 32655-32661.
55. Hubbard, G. P., Wolffram, S., Lovegrove, J. A. & Gibbins, J. M. (2004) Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J. Thromb. Haemost. 2: 2138-2145.